skip to Main Content

Mission Statement

To accelerate haemato-oncology patient access to novel therapies, combinations and cellular therapies, and improve outcomes for patients. To attract, support and deliver research trials in the UK for patients with blood cancer.


  • Create a sustainable infrastructure to run haemato-oncology trials in the UK giving patients access to novel drug, stem cell transplant and cellular therapies
  • Generate practice changing quality data to benefit patients
  • Increase UK trial capacity to deliver pivotal blood cancer trials
  • Align with UK NIHR and NCRI strategy
  • Create an integrated trial proposition with the potential to increase the number of future trials of novel therapies
  • Empower and resource the current and next generation of clinical investigators and research nurses